Blog
RSS FeedPosted by Michael Wonder on 20 Mar 2023
Resignations at Canada’s drug pricing panel raise independence questions
14 March 2023 - A member of Canada’s drug pricing regulator has resigned, stating the federal government has undermined the ...
Posted by Michael Wonder on 19 Mar 2023
Lower drug prices are a good thing. Canada’s approach to achieving them was not.
17 March 2023 - Over the past six years, the Patented Medicine Prices Review Board – Canada’s federal drug-price regulating agency ...
Posted by Michael Wonder on 16 Mar 2023
First drugs facing Medicare price penalty are named
15 March 2023 - US lists 27 medications whose prices rose faster than inflation, triggering rebates under new law. ...
Posted by Michael Wonder on 16 Mar 2023
Sanofi cuts US list price of Lantus, its most prescribed insulin, by 78% and caps out of pocket Lantus costs at $35 for all patients with commercial insurance
16 March 2023 - Sanofi announces that it will cut the list price of Lantus (insulin glargine injection) 100 units/mL, ...
Posted by Michael Wonder on 16 Mar 2023
ICER publishes white paper on using comparative effectiveness research to address prescription drug spending in California
16 March 2023 - State policy makers and purchasers in California are uniquely positioned to further integrate comparative effectiveness research ...
Posted by Michael Wonder on 15 Mar 2023
HHS releases initial guidance for historic Medicare drug price negotiation program for price applicability year 2026
15 March 2023 - For the first time, Medicare will be able to negotiate prices directly with drug companies, ensuring ...
Posted by Michael Wonder on 15 Mar 2023
Inflation Reduction Act tamps down on prescription drug price increases above inflation
15 March 2023 - HHS announces savings for some people with Medicare on 27 Part B prescription drugs. ...
Posted by Michael Wonder on 14 Mar 2023
BMS, Pfizer, AbbVie drugs likely to face US price negotiation
13 March 2023 - The blood thinner Eliquis from BMS, Pfizer's breast cancer drug Ibrance and AbbVie's leukaemia treatment Imbruvica ...
Posted by Michael Wonder on 14 Mar 2023
Novo Nordisk to lower US prices of several pre-filled insulin pens and vials up to 75% for people living with diabetes in January 2024
14 March 2023 - Novo Nordisk currently provides co-pay support for a number of insulin products meaning eligible patients can pay ...
Posted by Michael Wonder on 12 Mar 2023
The value of medical innovation versus industry rewards
10 March 2023 - This article provides systematic evidence on the share of the value of health generated by drugs and ...
Posted by Michael Wonder on 11 Mar 2023
Drug pricing throughout the product lifecycle: a work in progress
10 March 2023 - Increases in drug prices and drug spending are of concern to health systems worldwide. This has naturally ...
Posted by Michael Wonder on 10 Mar 2023
Medicare will take R&D costs, effectiveness into account when it negotiates drug prices. But studies show that doesn’t affect prices.
10 March 2023 - By law, Medicare will have to take a medication’s efficacy and its research and development costs ...
Posted by Michael Wonder on 09 Mar 2023
Patent system key to lower drug prices, experts say
9 March 2023 - Following the Biden administration’s progress towards lowering prescription drug prices with Medicare price negotiations, some industry ...
Posted by Michael Wonder on 09 Mar 2023
New drugs are coming to market at sky-high prices
9 March 2023 - Trend follows rising pressure on companies to rein in repeat or annual price hikes for older drugs/ ...
Posted by Michael Wonder on 05 Mar 2023
Medicine and medical device pricing and reimbursement in Netherlands
2 March 2023 - Since the Netherlands is a Member State of the European Union, it has implemented the European ...